Revvity (RVTY)

Company Profile

as a leader focused on improving human and environmental health, we are helping scientists, clinicians, and government agencies discover more effective diagnostics and therapies, and making sure that the food we eat and the air we breathe are safe from contaminants. environmental health overview at perkinelmer, we’re taking action to ensure the quality of our environment. the ability to rapidly detect known and unknown contaminants in our food, water and air, or to monitor their quality consistently, is an important part of maintaining a healthy environment. our systems and services help scientists understand all of these complexities and ensure compliance. from food safety to air & water quality, perkinelmer transforms information into results that improve our health and safety today and our world tomorrow. human health overview perkinelmer creates life science research and diagnostic instrumentation as well as informatics and diagnostic lab services—all to fight illness proacti

Company profile

Ticker

RVTY

Exchange

NYSE

Website

www.perkinelmer.com/

CEO

Prahlad Singh

Incorporated

Massachusetts

Location

Massachusetts

Fiscal year end

Dec 29

Sector

Manufacturing > Analytical Laboratory Instrument Manufacturing

Industry (SIC)

Laboratory Analytical Instruments

Agilent • Bio-Rad Laboratories • Waters • Illumina • Avantor • Mettler-Toledo International • Bruker • Seer • Prenetics Global Limited • Cue Health ...

Former names

EG&G INC, PERKINELMER INC

SEC CIK

0000031791

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

2Cure, LLC • BioLegend CNS, Inc. • BioLegend Ventures, LLC • BioLegend, Inc. • Caliper Life Sciences, Inc. • Cambridge Research • Dharmacon, Inc. • Horizon Discovery, Inc. • Immunodiagnostic Systems Inc. • Nexcelom Bioscience Holdings, LLC ...

IRS number

42052042

RVTY stock data

1M 1Y 5Y

Analyst ratings and price targets

Last 3 months

Latest filings (excl ownership)

View all

9 Aug 23

Results of Operations and Financial Condition

1 Aug 23

Conflict minerals disclosure

12 May 23

Results of Operations and Financial Condition

11 May 23

8-K

Amendments to Articles of Incorporation or Bylaws

28 Apr 23

8-K

Entry into a Material Definitive Agreement

15 Mar 23

ARS

2023 FY

Annual report to shareholders

8 Mar 23

DEFA14A

Additional proxy soliciting materials

8 Mar 23

DEF 14A

Definitive proxy

8 Mar 23

Transcripts

View all

RVTY

Earnings call transcript

2023 Q2

1 Aug 23

RVTY

Earnings call transcript

2023 Q1

11 May 23

RVTY

Earnings call transcript

2022 Q3

8 Nov 22

RVTY

Earnings call transcript

2022 Q2

5 Aug 22

RVTY

Earnings call transcript

2022 Q1

4 May 22

RVTY

Earnings call transcript

2021 Q4

2 Feb 22

RVTY

Earnings call transcript

2021 Q3

3 Nov 21

RVTY

Earnings call transcript

2021 Q2

29 Jul 21

RVTY

Earnings call transcript

2021 Q1

5 May 21

RVTY

Earnings call transcript

2020 Q4

3 Feb 21

Latest ownership filings

View all

11-K/A

Annual report of employee stock purchases (amended)

21 Jul 23

11-K

Annual report of employee stock purchases

T. Rowe Price Investment Management, Inc.

Financial summary

Financial statements Chart RVTY financial data

Quarter (USD)	Jul 23	Apr 23	Jan 23	Oct 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Jan 23	Jan 22	Jan 21	Dec 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	1.33 bn	1.33 bn	1.33 bn	1.33 bn	1.33 bn	1.33 bn
Cash burn (monthly)	311.75 mm	(no burn)	(no burn)	(no burn)	45.11 mm	(no burn)
Cash used (since last report)	854.16 mm	n/a	n/a	n/a	123.59 mm	n/a
Cash remaining	479.16 mm	n/a	n/a	n/a	1.21 bn	n/a
Runway (months of cash)	1.5	n/a	n/a	n/a	26.8	n/a

Beta Read what these cash burn values mean

Financial data from Revvity earnings reports.

Institutional ownership, Q2 2023

RVTY institutional ownership history Ownership history

82.4% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	504	543	-7.2%
Opened positions	43	45	-4.4%
Closed positions	82	98	-16.3%
Increased positions	148	204	-27.5%
Reduced positions	204	185	+10.3%

13F shares	Current	Prev Q	Change
Total value	12.11 tn	13.71 tn	-11.7%
Total shares	102.32 mm	102.89 mm	-0.5%
Total puts	50.60 k	76.10 k	-33.5%
Total calls	84.80 k	57.10 k	+48.5%
Total put/call ratio	0.6	1.3	-55.2%

Largest owners	Shares	Value	Change
Vanguard	14.51 mm	$1.72 tn	-1.1%
T. Rowe Price Investment Management	12.72 mm	$1.51 tn	+27.6%
Select Equity	11.36 mm	$1.35 tn	+14.3%
BLK Blackrock	8.48 mm	$1.01 tn	-1.2%
Capital Research Global Investors	8.29 mm	$984.85 bn	-30.0%
STT State Street	5.28 mm	$627.80 bn	+1.9%
JHG Janus Henderson	4.65 mm	$551.92 bn	+122.1%
Geode Capital Management	2.64 mm	$312.56 bn	+1.5%
Pictet Asset Management	2.13 mm	$253.42 bn	+6.1%
MS Morgan Stanley	1.61 mm	$191.31 bn	+41.8%

Largest transactions	Shares	Bought/sold	Change
Capital Research Global Investors	8.29 mm	-3.55 mm	-30.0%
T. Rowe Price Investment Management	12.72 mm	+2.75 mm	+27.6%
JHG Janus Henderson	4.65 mm	+2.55 mm	+122.1%
Citadel Advisors	752.36 k	-2.38 mm	-76.0%
Massachusetts Financial Services	773.20 k	-1.51 mm	-66.2%
Select Equity	11.36 mm	+1.42 mm	+14.3%
Millennium Management	1.21 mm	+1.21 mm	NEW
Mitsubishi UFJ Kokusai Asset Management	781.41 k	+680.53 k	+674.6%
Perpetual	0.00	-588.68 k	EXIT
MS Morgan Stanley	1.61 mm	+474.76 k	+41.8%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

RVTY insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
15 Jun 23	Anita Gonzales	Common Stock	Grant	Acquire A	No	No	0	329	0.00	3,611
15 Jun 23	Anita Gonzales	NQ Stock Option Common Stock	Grant	Acquire A	No	No	116.36	947	110.19 k	947
15 May 23	Chapin Samuel R.	Common Stock	Grant	Acquire A	No	No	0	955	0.00	15,789
15 May 23	Chapin Samuel R.	Common Stock	Grant	Acquire A	No	No	0	783	0.00	14,834
15 May 23	Michas Alexis P	Common Stock	Grant	Acquire A	No	No	0	1,372	0.00	60,584
15 May 23	Michas Alexis P	Common Stock	Grant	Acquire A	No	No	0	1,061	0.00	59,212
15 May 23	Witney Frank	Common Stock	Grant	Acquire A	No	No	0	955	0.00	16,467
15 May 23	Witney Frank	Common Stock	Grant	Acquire A	No	No	0	783	0.00	15,512
15 May 23	Gregoire Sylvie	Common Stock	Grant	Acquire A	No	No	0	955	0.00	20,482
15 May 23	Gregoire Sylvie	Common Stock	Grant	Acquire A	No	No	0	783	0.00	19,527